BACKGROUND: To investigate the function of the intestinal Vdr gene in inflammatory bowel disease (IBD), in conjunction with the discovery of possible metabolic markers for IBD using intestine-specific Vdr knockout mice. METHODS: Vdr(ΔIEpC) mice were generated, phenotyped and treated with a time-course of 3% dextran sulfate sodium (DSS) to induce colitis. Colitis was diagnosed by evaluating clinical symptoms and intestinal histopathology. Gene expression analysis was carried out. In addition, metabolic markers of IBD were explored by metabolomics. RESULTS: Vdr(ΔIEpC) mice showed abnormal body size, colon structures and feces color. Calcium, collagen, and intestinal proliferation-related gene expression were all decreased, and serum alkaline phosphatase was highly increased. In the acute model which was treated with 3% DSS for six days, Vdr(ΔIEpC) mice showed a high score of IBD symptoms; enlarged mucosal layer and damaged muscularis layer. In the recovery experiment model, where mice were treated with 3% DSS for four days and water for three days, Vdr(ΔIEpC) mice showed a high score of IBD symptoms; severe damage of mucosal layer and increased expression of genes encoding proinflammatory cytokines. Feces metabolomics revealed decreased concentrations of taurine, taurocholic acid, taurodeoxycholic acid and cholic acid in Vdr(ΔIEpC) mice. CONCLUSIONS: Disruption of the intestinal Vdr gene showed phenotypical changes that may exacerbate IBD. These results suggest that VDR may play an important role in IBD. GENERAL SIGNIFICANCE: VDR function has been implicated in IBD. This is of value for understanding the etiology of IBD and for development of diagnostic biomarkers for IBD. Published by Elsevier B.V.
BACKGROUND: To investigate the function of the intestinal Vdr gene in inflammatory bowel disease (IBD), in conjunction with the discovery of possible metabolic markers for IBD using intestine-specific Vdr knockout mice. METHODS:Vdr(ΔIEpC) mice were generated, phenotyped and treated with a time-course of 3% dextran sulfate sodium (DSS) to induce colitis. Colitis was diagnosed by evaluating clinical symptoms and intestinal histopathology. Gene expression analysis was carried out. In addition, metabolic markers of IBD were explored by metabolomics. RESULTS:Vdr(ΔIEpC) mice showed abnormal body size, colon structures and feces color. Calcium, collagen, and intestinal proliferation-related gene expression were all decreased, and serum alkaline phosphatase was highly increased. In the acute model which was treated with 3% DSS for six days, Vdr(ΔIEpC) mice showed a high score of IBD symptoms; enlarged mucosal layer and damaged muscularis layer. In the recovery experiment model, where mice were treated with 3% DSS for four days and water for three days, Vdr(ΔIEpC) mice showed a high score of IBD symptoms; severe damage of mucosal layer and increased expression of genes encoding proinflammatory cytokines. Feces metabolomics revealed decreased concentrations of taurine, taurocholic acid, taurodeoxycholic acid and cholic acid in Vdr(ΔIEpC) mice. CONCLUSIONS: Disruption of the intestinal Vdr gene showed phenotypical changes that may exacerbate IBD. These results suggest that VDR may play an important role in IBD. GENERAL SIGNIFICANCE: VDR function has been implicated in IBD. This is of value for understanding the etiology of IBD and for development of diagnostic biomarkers for IBD. Published by Elsevier B.V.
Authors: Marc-Emmanuel Dumas; Richard H Barton; Ayo Toye; Olivier Cloarec; Christine Blancher; Alice Rothwell; Jane Fearnside; Roger Tatoud; Véronique Blanc; John C Lindon; Steve C Mitchell; Elaine Holmes; Mark I McCarthy; James Scott; Dominique Gauguier; Jeremy K Nicholson Journal: Proc Natl Acad Sci U S A Date: 2006-08-08 Impact factor: 11.205
Authors: A R Baker; D P McDonnell; M Hughes; T M Crisp; D J Mangelsdorf; M R Haussler; J W Pike; J Shine; B W O'Malley Journal: Proc Natl Acad Sci U S A Date: 1988-05 Impact factor: 11.205
Authors: Raffaella M Gadaleta; Bas Oldenburg; Ellen C L Willemsen; Maureen Spit; Stefania Murzilli; Lorena Salvatore; Leo W J Klomp; Peter D Siersema; Karel J van Erpecum; Saskia W C van Mil Journal: Biochim Biophys Acta Date: 2011-04-22
Authors: Fa Wang; Robert L Johnson; Marsha L DeSmet; Paul W Snyder; Keke C Fairfax; James C Fleet Journal: Endocrinology Date: 2017-06-01 Impact factor: 4.736
Authors: Lei He; Tianjing Liu; Yongyan Shi; Feng Tian; Huiyuan Hu; Dilip K Deb; Yinyin Chen; Marc Bissonnette; Yan Chun Li Journal: Endocrinology Date: 2018-02-01 Impact factor: 4.736
Authors: Stacey Meeker; Audrey Seamons; Jisun Paik; Piper M Treuting; Thea Brabb; William M Grady; Lillian Maggio-Price Journal: Cancer Res Date: 2014-06-17 Impact factor: 12.701
Authors: Yong-Guo Zhang; Rong Lu; Yinglin Xia; David Zhou; Elaine Petrof; Erika C Claud; Jun Sun Journal: Inflamm Bowel Dis Date: 2019-01-01 Impact factor: 5.325
Authors: Jie Cheng; Zhong-Ze Fang; Jung-Hwan Kim; Kristopher W Krausz; Naoki Tanaka; John Y L Chiang; Frank J Gonzalez Journal: J Lipid Res Date: 2013-12-16 Impact factor: 5.922